{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:53:12Z","timestamp":1768837992012,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.575805","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T05:45:09Z","timestamp":1601012709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Antti","family":"N\u00e4tynki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Tuusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Hervonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Kaukinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Huilaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kokkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teea","family":"Salmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2340\/00015555-3401","article-title":"Current concepts of dermatitis herpetiformis","volume":"100","author":"Salmi","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19022","article-title":"Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study","author":"Persson","year":"2020","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","article-title":"Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland","volume":"165","author":"Salmi","year":"2011","journal-title":"Br J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jid.2018.10.010","article-title":"Dermatitis herpetiformis and celiac disease increase the risk of bullous pemphigoid","volume":"139","author":"Varpuluoma","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/ced.13992","article-title":"Dermatitis herpetiformis","volume":"44","author":"Salmi","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis herpetiformis: novel perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/jid.2009.142","article-title":"IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease","volume":"129","author":"Jaskowski","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"S\u00e1rdy","year":"2002","journal-title":"J Exp Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MCG.0000000000000533","article-title":"The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45-year experience in 393 patients","volume":"51","author":"Mansikka","year":"2017","journal-title":"J Clin Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2340\/00015555-3399","article-title":"Collagen XVII processing and blistering skin diseases","volume":"100","author":"Nishie","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jid.2017.07.831","article-title":"C-terminal processing of collagen XVII induces neoepitopes for linear iga dermatosis autoantibodies","volume":"137","author":"Toyonaga","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jid.2019.03.1150","article-title":"Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet-treated dermatitis herpetiformis","volume":"139","author":"Mansikka","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/bjd.13189","article-title":"Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital","volume":"171","author":"F\u00f6rsti","year":"2014","journal-title":"Br J Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"24521","DOI":"10.1074\/jbc.M308835200","article-title":"Shedding of collagen XVII\/BP180: structural motifs influence cleavage from cell surface","volume":"279","author":"Franzke","year":"2004","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in alzheimer's disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jid.2018.09.010","article-title":"BP180 autoantibodies target different epitopes in multiple sclerosis or alzheimer's disease than in bullous pemphigoid","volume":"139","author":"Tuusa","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/jid.2008.424","article-title":"Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97","volume":"129","author":"Hofmann","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis","volume":"30","author":"Lai","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","article-title":"Vildagliptin significantly increases the risk of bullous pemphigoid: a finnish nationwide registry study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jid.2018.10.045","article-title":"Higher frequency of dipeptidyl peptidase-4 inhibitor intake in bullous pemphigoid patients than in the french general population","volume":"139","author":"Plaquevent","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","article-title":"B cell epitope spreading: mechanisms and contribution to autoimmune diseases","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jid.2015.12.005","article-title":"Autoantibodies to collagen XVII are present in parkinson's disease and localize to tyrosine-hydroxylase positive neurons","volume":"136","author":"Messingham","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1003273","article-title":"Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology","volume":"186","author":"Zone","year":"2011","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2133.2009.09266.x","article-title":"IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses","volume":"161","author":"Feliciani","year":"2009","journal-title":"Br J Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/bjd.12739","article-title":"Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited","volume":"170","author":"van Beek","year":"2014","journal-title":"Br J Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jaad.2018.06.006","article-title":"Circulating bullous pemphigoid 180 autoantibody can be detected in a wide spectrum of patients with other dermatologic conditions: a cross-sectional study","volume":"80","author":"Liu","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ijd.13925","article-title":"A subset of patients with pemphigoid (herpes) gestationis has serological evidence of celiac disease","volume":"57","author":"Saffari","year":"2018","journal-title":"Int J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1756-0500-7-310","article-title":"Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis","volume":"7","author":"Ress","year":"2014","journal-title":"BMC Res Notes."},{"key":"B37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000349982","article-title":"Concomitant bullous pemphigoid and dermatitis herpetiformis","volume":"226","author":"Schulze","year":"2013","journal-title":"Dermatology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","article-title":"Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients","volume":"167","author":"Hervonen","year":"2012","journal-title":"Br J Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horvath","year":"2010","journal-title":"Exp Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1087-0024.2004.00840.x","article-title":"IgA autoimmune disorders: development of a passive transfer mouse model","volume":"9","author":"Zone","year":"2004","journal-title":"J Investig Dermatol Symp Proc."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.575805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T05:45:24Z","timestamp":1601012724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.575805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2020.575805"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.575805","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"article-number":"575805"}}